通用资产管理公司在West Pharming Services公司获得重大股份,价值约10.75亿美元。 Generali Asset Management acquired a significant stake in West Pharmaceutical Services, valued at about $1.075 million.

瑞士集团资产管理公司 (Generali Asset Management SPA SGR) 在第四季度收购了西制药服务公司 (WST) 的重要股权,收购了价值约1,075,000美元的3,283股股票. Generali Asset Management SPA SGR bought a significant stake in West Pharmaceutical Services, Inc. (WST) in Q4, acquiring 3,283 shares valued at about $1,075,000. 该公司报告说,Q4收入强劲,每股1.82美元,超过分析师的预期。 The company reported strong Q4 earnings of $1.82 per share, surpassing analysts' expectations. 西方制药服务公司的市场上限为164.5亿美元,物价与收入比率为34.02。 West Pharmaceutical Services has a market cap of $16.45 billion and a price-to-earnings ratio of 34.02. Evercore ISI 对该公司股票发布了跑赢大盘评级，目标价为 275.00 美元。 Evercore ISI issued an outperform rating with a $275.00 target price on the company's stock.